A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma

NCT07533942 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningioma

Interventions

DRUG: JZP3507

Sponsor

Jazz Pharmaceuticals

Collaborators

[object Object]